Introduction
============

The notochord is an important feature of the phylum Chordata [@B1], and is fully differentiated during early embryogenesis of the anterior-posterior body axis through polarization [@B2]. The notochord is a center of signaling transmission, and also acts as the axial skeleton and neural tube of the embryo [@B3]. Notochord structure differentiates from the chordamesoderm (part of the mesoderm) during zebrafish embryo gastrulation [@B4]. At this stage, notochord progenitor cells differentiate, turn into rod-like vacuolated cells at the midline in the trunk, and grow in concert with somatic segmentation. Notochord structure forms through the cross-linking of collagen, elastin, and other extracellular proteins [@B5]. Certain notochord cells subsequently contribute to the formation of the nucleus pulposus (NP) of intervertebral discs (IVDs) [@B3], [@B6], [@B7], suggesting that defects in notochord development may be related to IVD development and degeneration [@B8], [@B9].

Collagen is one of the proteins required for notochord formation. It is also found in a variety of tissues, including cartilage, bone, blood vessels, and the gut. The proteins of the collagen family are diverse in function, but all share a common structural feature, consisting of at least one triple-helical domain corresponding to a number of (Gly-X-Y)n repeats (X is frequently proline, and Y is often hydroxyproline) [@B10]. To date, more than 50 types of collagen and collagen-like protein have been identified [@B11]. Most collagen in the body is type I, while type II is the main component of cartilage. Cartilage is composed of chondroblasts, which produce a large amount of extracellular matrix consisting of type II collagen. Collagen type 2 alpha 1 (col2a1) is a major matrix protein found in cartilage; this protein provides tensile strength and a scaffolding network for proteoglycans [@B10], [@B12], and has been found to be conserved from mammals to teleosts. It can be detected in the developing cartilage, notochord, skin, floor plate, brain, heart, and other tissues [@B13]-[@B16]. Certain mutations in the *col2a1* gene have been linked to type II collagenopathies, which include Stickler syndrome type 1 [@B17]. Stickler syndrome is a genetic disorder of connective tissue, characterized by abnormal skeletal growth and density, early onset of osteoarthritis, and retinal detachment, as first described by Stickler [@B18]-[@B20]. Mutations in *col2a1*, *col11a1*, *col11a2*, and *col9a1* have been reported to cause type 1 to 4 Stickler syndrome [@B21], [@B22]. Haploinsufficiency of *col2a1*expression, arising from gene silencing or nonsense mutations, is linked to Stickler syndrome [@B23]. Thus, sufficient production of *col2a1*protein is essential for normal skeletal and cartilage development.

Gene duplication in the zebrafish genome is common [@B24], [@B25], and there are two homologues of mammalian *col2a1* gene in zebrafish. The *col2a1a* gene has been well characterized [@B26], but the expression pattern and function of the *col2a1b* gene are unclear. Tg(*col2a1a*:GFP), a transgenic zebrafish line expressing GFP under the control of the *col2a1a* promoter, was recently generated, and found to express GFP in craniofacial cartilage, ear, notochord, floor plate, hypochord, pectoral fins, and IVD, a pattern similar to that of endogenous *col2a1a*[@B27]. Expression of *col2a1* in chondrocytes is known to be directly regulated by Sox9 during chondrogenesis in mammals. Sox9 is a member of the vertebrate SoxE family (all of which contain a high-mobility-group (HMG)-box DNA-binding domain), and its effect on *col2a1* expression is enhanced by Sox5 and Sox6, which act as cofactors that bind to Sox9 [@B28]-[@B31]. Attempts have been made to identify other transcriptional partners of mammalian Sox9 to better understand the regulatory mechanisms involved in *col2a1* activation. However, unlike its mammalian counterpart, zebrafish has two paralogues of the *sox9* gene, termed *sox9a* and *sox9b*. Previous reports have indicated that the expression patterns of Sox9a and Sox9b are distinct, but overlap in some parts of the brain, craniofacial skeleton, notochord and fins during embryogenesis [@B32]-[@B34]. .Knockdown of *Sox9a* caused a significant decrease in the GFP signal in craniofacial cartilage, while the GFP signal in notochord remained unchanged [@B27]. This suggests that factors other than Sox9a are required for expression of *col2a1a* in zebrafish notochord. Recently, zinc finger protein 219 (ZNF219) was reported to act as a transcriptional partner of Sox9 in the regulation of chondrocyte differentiation in mammals [@B35]-[@B37]. In mice, expression of z*nf219*mRNA is detected specifically in the developing limb buds, where *col2a1* and *sox9* are also expressed [@B37]. ZNF219 has been shown to colocalize with Sox9 in the nucleus. ZNF219 increases activity of the *col2a1*gene promoter by upregulating the transcriptional activity of Sox9. This suggests that ZNF219 may affect *col2a1* expression by forming a complex with Sox9 [@B37].

In mammals, *znf219*was originally isolated from a human testis cDNA library; it encodes a protein of 723 amino acids with nine individual Cys2His2 (C2H2) zinc finger domains, eight of which are separated-paired [@B38], [@B39]. In general, C2H2-type zinc finger proteins can be divided into three groups: triple-C2H2, multiple-adjacent-C2H2, and separated-paired-C2H2. Their functions are diverse, due to their zinc finger structures [@B40]. There are more than 10,000 types of C2H2 zinc finger domains. It has been reported that classical C2H2 zinc finger proteins are involved in DNA binding, and function in transcriptional regulation. There is considerable variation in zinc finger proteins between different species [@B38], [@B39]. Whole genome analysis has been used to predict that there are 216, 837, and 1055 genes encoding C2H2-type zinc finger proteins in the genomes of zebrafish, mouse, and human, respectively [@B38]. As there are far fewer C2H2 zinc finger proteins in zebrafish than in mammals, it is plausible that zebrafish zinc finger proteins may diverge greatly in terms of their amino acid sequences, and have similar or overlapping functions as compared with their mammalian counterparts.

In this study, we describe theisolation of zebrafish ZNF219-like (ZNF219L) gene, which encodes a novel transcription factor. We demonstrate that ZNF219L recognizes the conserved GGGGG motifs in the *col2a1a* promoter region, and it regulates *col2a1a* expression specifically in zebrafish notochord during early stages. Our results indicate that zinc finger domain-containing protein, ZNF219L, might have predominant roles in regulating *col2a1a* expression in notochord specifically.

Materials and methods
=====================

Zebrafish care
--------------

Zebrafish embryos were raised at 28.5 °C, and different developmental stages were determined based on criteria described in the *Zebrafish Book* [@B41]. All animal procedures were approved by Academia Sinica Institutional Animal Care and Utilization Committee (ASIACUC) (protocol \#10-12-114).

Rapid Amplification of cDNA Ends (RACE)
---------------------------------------

In order to obtain full-length cDNA, the 5\' ends of zebrafish *znf219L* mRNA were amplified by random amplification of cDNA 5\' ends (RACE) PCR using a Marathon cDNA amplification kit (Clontech, Palo Alto, CA, USA) according to the supplier\'s instructions. In brief, total RNA was isolated from zebrafish kidney or heart by the guanidinium thiocyanate method [@B42], and poly(A)+ RNA was subsequently prepared. First-strand cDNA was synthesized using a modified poly-T primer and 1 μg of poly (A)+ RNA. Second-strand cDNA was generated using an enzyme cocktail containing RNase H, DNA polymerase, and DNA ligase. Asymmetric adapter primers (AP primers) were then ligated to both ends of the double-stranded cDNA. An aliquot of this zebrafish cDNA collection was diluted 1:100 and subjected to two different anchored PCRs. 5\' RACE was first performed with a 27-mer sense primer (AP1) against the adapter and an anti-sense primer against *znf219L* (5\'- GGG GAA GGA ATT GGG GAC TGT GGT CCA GGG ATG GCA TGG AGG GAG GAG ACA G-3\'); the second round of PCR was carried out with a nested 23-mer sense primer (AP2) and a nested antisense primer against *znf219L* (5\'-TGG GGG CTC AGA GGA AAG AGC CAG CAT ACA TTC TGG TGG GGA ATC CAT -3\'). The PCR products were cloned into the pGEM-T vector (Promega, Madison, WI, USA) and sequenced.

Cloning of full-length and deletion mutations of zebrafish z*nf219L*
--------------------------------------------------------------------

The *znf219L*sequence was submitted to GenBank with the accession no. JX141438. Full-length and deletion variants of the zebrafish *znf219L* coding sequence were generated by PCR amplification using gene-specific primers, as shown in Table [1](#T1){ref-type="table"}. In order to express fusion proteins of ZNF219L (or ZNF219L deletion mutants tagged with HA) in NIH3T3 cells, PCR products of full-length ZNF219L or deletion mutant forms of ZNF219L were ligated into pGEM-T-easy vector (Promega) through TA cloning, and then further sub-cloned into pcDNA3-HA (Invitrogen, Carlsbad, CA, USA) via *Hind*III and *Kpn*I restriction enzyme sites. The expression vectors were transfected into NIH3T3 using the transfection protocol described in the following section.

Luciferase reporter gene assay
------------------------------

Luciferase reporter gene assay was performed using pGL3 Luciferase Reporter Vectors (Promega), which contained a modified coding region for firefly (*Photinus pyralis*) luciferase driven by the zebrafish *col2a1a*-386 proximal promoter and -386 mut (all three zZNF219L binding sites were mutated from GGGGG to GAAAG by PCR mutagenesis). The following primers were used to amplify the zebrafish *col2a1a*-386 proximal and -386 mut promoter: forward primer: 5\'- AAG CCC ACC ACT TGC CAG GAA A-3\'; reverse primer: 5\'- TTG GAT GTG GAT GTG TTT GGG-3\'. The luciferase reporter constructs were transfected into carp fin epithelioid cells. One microgram of promoter DNA and 0.5 mg of pSV-β-galactosidase were co-transfected using the PolyJet In Vitro DNA Transfection Reagent (SignaGen Laboratories, Ijamsville, MD, USA) into carp fin epithelioid cells. Transfections were performed using 12-well plates, and approximately 1x10^5^ cells were seeded one day before transfection. Cells were lysed two days after transfection (by which time cells had grown to 90% confluency), and luciferase activity was determined using a luminometer (Promega), according to the manufacturer\'s protocol. Transfection efficiency was normalized by determining the activity of β-galactosidase activity in the cell lysates. All presented data are the results of three independent experiments, and were statistically analyzed by one-way ANOVA. Data represent mean ± s.d.

Total RNA isolation and reverse-transcription polymerase chain reaction (RT-PCR) analysis of zebrafish *znf219L* mRNA
---------------------------------------------------------------------------------------------------------------------

Total RNA (from different developmental stages and tissues of adult zebrafish) was isolated using the RNAzol reagent (Tel-Test, Friendswood, TX, USA), according to the manufacturer\'s instructions. After treatment with RQ1 RNase-Free DNase I (Promega), 50\~100 μg of total RNA were subjected to first-strand cDNA synthesis. The following primers were used to amplify zebrafish *znf219L*: *znf219L*-RT-F, 5\'-GCA TGG AGC GCC TTC AGG CAG TGG CAC-3\', and *znf219L*-RT-R, 5\'-GCA GAT GCA GAA GAG CCC TCC TTC TTC-3\'. Zebrafish β-actin was amplified as an internal control, using the following primers: zACT-F, 5\'-GTG CTA GAC TCT GGT GAT GGT GTG-3\', and zACT-R, 5\'-GGT GAT GAC CTG ACC GTC AGG AAG-3\'.

Morpholino oligonucleotide (MO) injection
-----------------------------------------

Antisense MOs were obtained from Gene Tools (Philomath, OR, USA). The sequences of the *znf219L* and control morpholinos were as follows: zebrafish *znf219L* ATG morpholino: 5\'-GTCTATGCCATGCTTCACTTCCTTG-3\', *znf219L* splicing morpholino: 5\'-GCCTCTCGCCTAAAACAAGGAATAA-3\', and control morpholino: 5\'-CCTCTTACCTCAGTTACAATTTATA-3\'. The morpholinos were diluted to form a 24 μg/μl injection stock, which was stored at -20 °C prior to use. The MO injection stock was injected into wild-type (WT) zebrafish embryos at the 1\~2-cell stage using a microinjection system consisting of an SZX9 stereomicroscope (Olympus, Tokyo, Japan) and an IM300 Microinjector (Narishige, Tokyo, Japan). The sequence of the p53 MO was as follows: 5\'-AAAATGTCTGTACTATCTCCATCCG-3\') [@B43]. The following primers were used for RT-PCR amplification of zebrafish *znf219L* in control (C) and *znf219L* splicing morpholino (MOs)-injected embryos: *znf219L*-F1, 5\'-CCG GGA GCT TCC ATT CTG TCA TAT C -3\', *znf219L*-F2, 5\'- GCA CAC CTC AGG CGG TAT TTA ATT GG-3\', and *znf219L*-R1, 5\'-CTG GGT GCC AGC ATA ATC ACA GTG G -3\'. Zebrafish β-actin was amplified as an internal control, using the following primers: zACT-F, 5\'-GTG CTA GAC TCT GGT GAT GGT GTG-3\', and zACT-R, 5\'-GGT GAT GAC CTG ACC GTC AGG AAG-3\'.

Whole-mount *in situ*hybridization
----------------------------------

Digoxigenin-labeled RNA probes (Roche, Penzberg, Germany) were generated by *in vitro*transcription of linearized pGEM-T-easy plasmids (Promega) carrying the 5\'-UTR of the following zebrafish genes (primers are indicated in parentheses): *znf219L* (*znf219L*-F, 5\'- GGA AGT GAA GCA TGG CAT AGA CAC ATC-3\', and *znf219L*-R, 5\'- GAC CAG AAG AGA TCG CCT TCT CAA GAG - 3\'), and *col2a1a*(*col2a1a*-F, 5\'-CCT AAA ATC CCA CGC AAG AA -3\', and *col2a1a*-R, 5\'- CTT GCA GCC ATC CTC AAG TA-3\'). Riboprobes for the detection of *col2a1b* [@B27], *col8a1a*[@B44], *col11a1a*[@B45], and *col27a1a*[@B46] were used as previously described. Whole-mount *in situ*hybridization was performed following a previously described protocol [@B47].

Microinjection of zebrafish embryos
-----------------------------------

In order to obtain stable transgenic fish, one-cell stage embryos were co-injected with 10 ng/μl *col2a1a*-2.1kb-*gfp* plasmid, 5 ng/μl capped Tol2 transposase mRNA, and 0.1% phenol red, as previously described [@B48]. The pCS-TP plasmid [@B49] encoding the transposase was first linearized with the restriction enzyme *Not*I, and then used as a template for *in vitro* transcription with mMessage mMachine (Ambion, Foster city, CA), according to the manufacturer\'s protocol.

To generate germline transgenic zebrafish, injected embryos that produced GFP signals were raised to adulthood (F0), and were crossed with wild-type fish at 3-months of age. F1 embryos were examined under a fluorescence microscope for identification of germline-transmitted F0 founders. Positive F1 embryos were raised to adulthood, and were then screened in the same way to estimate copy numbers of the transgene, and to establish stable transgenic lines.

Cell cultures
-------------

Carp fin epithelioid cells, CF [@B50], were maintained in Leibovitz\'s L-15 media supplemented with 10% fetal bovine serum at 27°C. Transfection of nucleic acid into CF cells was carried out as previously described [@B51]. NIH/3T3 cells (ATCC CRL-1658; Manassas, VA, USA) were cultured in high-glucose Dulbecco\'s modified Eagle\'s media (DMEM) supplemented with 10% fetal bovine serum (FBS; Hyclone, Logan, UT, USA) in a humidified atmosphere of 5% CO~2~ at 37 ºC.

Oligonucleotide precipitation assay
-----------------------------------

NIH 3T3 cells were lysed in lysis buffer \[20 mM HEPES (pH 7.4), 150 mM NaCl, 1 mM EGTA, 1.5 mM MgCl~2~, 10% glycerol, 1% Triton X-100, 10 mg/ml leupeptin, 1 mM PMSF, 0.2 mM sodium orthovanadate\] for use in the *in vitro* binding assay. The lysates were pre-incubated with streptavidin-agarose beads for 3 hours, and then incubated for 16 hours with 1 mg of poly (dI-dC) and 1 mg of a biotinylated double-stranded oligonucleotide probe (which contained one of the three zZNF219L binding element repeats present in the *col2a1a*gene promoter binding site 1; BS-1 sense primer: 5\'-GGC AAA AAG GGG AGG GGG TGG ATG GGT TTG-3\'; anti-sense primer: 5\'- CAA ACC CAT CCA CCC CCT CCC CTT TTT GCC -3\'; BS-2 sense primer: 5\'- CAA TGG GGT GGG CTG GGG GGC TCG TAT TTC-3\'; anti-sense primer: 5\'- GAA ATA CGA GCC CCC CAG CCC ACC CCA TTG-3\'; BS-3 sense primer: 5\'- TTC AGC GCT CAT GGG GGT CGG GGT TGG ACT-3\'; anti-sense primer: 5\'- AGT CCA ACC CCG ACC CCC ATG AGC GCT GAA-3\'). Lysates were subsequently incubated with streptavidin agarose (Streptavidin Agarose, Invitrogen) for 1 hour. The bound-proteins were then washed with lysis buffer, separated on an SDS- polyacrylamide gel, and subjected to Western blot using antibodies against the proteins of interest.

Results
=======

Cloning of *znf219L* cDNA from zebrafish
----------------------------------------

To clone the zebrafish cDNA sequences related to the human *znf219* gene, we used the program tBLAST to search GenBank for expression sequence tags (ESTs) resembling a region of human ZNF219 that encodes the first three paired zinc fingers (amino acid residues 59 to 327). In this way, we identified one zebrafish EST clone (CR926852). We used 5\'- and 3\'-RACE to obtain the 5\'- and 3\'-untranslated regions (UTRs) of this clone, allowing us to assemble a 4101-bp cDNA with an open reading frame of 3288-bp, predicted to encode a protein of 1095 amino acid residues. The 5\'- and 3\'-UTRs were 237-bp and 576-bp in length, respectively. The complete sequence was deposited in GenBank with the accession number JX141438.

The overall predicted amino acid sequence of zebrafish ZNF219 has only 20% identity with its orthologues in human and mouse (Fig. [1](#F1){ref-type="fig"}B). However, the three paired zinc finger domains (aa 278-325, 358-408, and 701-749) of zebrafish ZNF219 have 58.3%, 84.3% and 95.9% identity with their equivalents in human ZNF219, respectively. In addition, zebrafish ZNF219 has two single zinc finger domains (aa 155-175 and 931-952) that have 80% identity with the corresponding domain of human ZNF219. Both human ZNF219 and zebrafish ZNF219 possess a non-homologous single zinc finger domain (the second and sixth domain, respectively (Fig. [1](#F1){ref-type="fig"}A). Based on its resemblance to ZNF219, we henceforth refer to the newly-identified protein as zebrafish ZNF219-like (ZNF219L).

Genomic organization of the zebrafish *znf219L*gene
---------------------------------------------------

Analysis of human, mouse, fugu, and zebrafish genomes show that znf219L are similarly present in these species. Examination of the genomic region around znf219 and a high degree of conserved genomic synteny was observed within four species, gene ARHGEF40 is flanking znf219L of four species while btr12 locates downstream of Fugu and zebrafish. ([Supplementary Fig. 1](#SF1){ref-type="supplementary-material"}). In mammals, ARHGEF40 is downstream of both human and mouse znf219L while it is upstream of fugu and zebrafish suggesting an inversion has occurred during chromosomal rearrangement after separation of the zebrafish lineage from mammals.

We then used the 4101-bp *znf219L*cDNA sequence to perform an online BLAST search of the GenBank database. The *znf219L*cDNA was found to show identity with 5 non-contiguous regions of two zebrafish BAC clones, DKEY-46I9 (GenBank accession no. BX664721, 130851-bp) and CH211-142D6 (GenBank accession no. AL929105, 178797-bp). BLAST two-sequence comparisons of each BAC clone with the zebrafish *znf219L*cDNA indicated that the *znf219L* sequence comprises 5 putative exons and 4 introns spanning at least 21.6 kb (Fig. [2](#F2){ref-type="fig"}).

Using these putative exons as a model, a sequence alignment was produced in which each intron was defined in accordance with the GT/AG intron donor/acceptor site rule [@B52]. Exons 1 and 2 contain 152-bp and 81-bp of the 5\'-UTR, respectively. Exon 3 contains 4-bp of the 5\'-UTR and the putative translation initiation site of the first coding sequence of the *znf-219L*cDNA. Exon 5 contains the last 1120-bp of the coding sequence and 576-bp of the 3\'-UTR. The size of the introns varied considerably, ranging from 76-bp (intron 2) to 17,577-bp (intron 1). Comparison of the exon-intron organization of zebrafish *znf219L* with that of the mouse and human *znf219* genes indicated that their genomic structures are similar in that all genes have 5 exons and 4 introns. The mouse and human *znf219*genes span approximately 14,657 and 8,595-bp, respectively. In addition, the first intron of the mouse (10,464-bp) and human *znf219* genes (4,637-bp) is smaller than that of the zebrafish *znf219L* gene (17,577-bp) (Fig. [2](#F2){ref-type="fig"}A).

Expression of zebrafish *znf219L*in various adult tissues and at different developmental stages
-----------------------------------------------------------------------------------------------

Expression of zebrafish *znf219L* in adult tissues and embryos of different developmental stages was examined by RT-PCR analysis. Primers were used to amplify a DNA fragment spanning exons 3 to 5, to avoid interference of the PCRs by genomic DNA. The amplified product was about 1,000-bp in length. Abundant *znf219L*expression was detected in heart and brain, with relatively low levels in muscle and testis of adult zebrafish. Expression of *znf219L* was detected from 24 hours post-fertilization (hpf) onwards at early developing stages (Fig. [2](#F2){ref-type="fig"}B, and [2](#F2){ref-type="fig"}C).

Expression patterns of *znf219L* mRNA in zebrafish embryos
----------------------------------------------------------

Previous studies reported that mouse *znf219* mRNA was specifically expressed in the developing limb buds, suggesting the encoded protein may play an important role in regulating chondrocyte differentiation. [@B37]. In order to investigate whether zebrafish ZNF219L is functionally related to mammalian ZNF219, we first examined its expression pattern by performing whole mount*in situ* hybridization using zebrafish embryos at different developmental stages. As shown in Fig. [2](#F2){ref-type="fig"}D, *znf219L* transcripts were first detected weakly at 22 hpf in notochord only (panels a and a\'). The expression level of *znf219L* increased in notochord, midbrain-hindbrain boundary and hindbrain from 22 to 72 hpf (panels b, b\', c and c\') and was nearly undetectable after 96 hpf (data not shown). The expression in pectoral fin and otic vesicle (ov) were only detected at 48 hpf (panel b).

Knockdown of *znf219L* caused partial notochord abnormalities
-------------------------------------------------------------

To characterize the physiological function of ZNF219L, we used ATG and splicing morpholinos to knockdown endogenous *znf219L* expression in zebrafish embryos. Knockdown of *znf219L* by ATG-MO caused a curved notochord phenotype, which showed slightly curved body axis (Fig. [3](#F3){ref-type="fig"}A, panels a, and a\'). Similar abnormalities in the notochord were observed in embryos injected with splicing morpholinos as well (Fig. [3](#F3){ref-type="fig"}B, panels a and a\'). Percentage of the curved notochord phenotype was correlated to the various doses of morpholino injected into the zebrafish embryos (Fig. [3](#F3){ref-type="fig"}C). It has been reported that concurrent knockdown of p53 can ameliorate the cell death induced by MO off-targeting [@B53]. Therefore, in order to rule out the possibilities that the phenotypes of the morphants were caused by the off-targeting effects of the morpholino used, coinjection of p53-MO and ATG-MO was performed. The percentage of abnormalities in the *znf219L*morphants coinjected with p53-MO was approximately equal to that with the various doses of morpholino used. Furthermore, co-injection of *znf219L* morphants with p53-MO did not result in a significant change in morphology, confirming the specificity of the *znf219L* morpholino (Fig. [3](#F3){ref-type="fig"}C).

In addition to ATG-MO, we also synthesized splicing-MO and the positions for splicing-MO targeting sites were shown (Fig. [3](#F3){ref-type="fig"}D, panel a). According to the results of RT-PCR analyses of the control (C) and splicing-MO (MOs)-injected embryos (Fig. [3](#F3){ref-type="fig"}D, panel b), the splicing-MO was effective to block mRNA splicing. Furthermore, embryos injected with splicing-MO exhibited similar curved notochord phenotype (Fig. [3](#F3){ref-type="fig"}B, panels a and a\') as that injected with ATG-MO. However, the ATG-MO consistently showed higher efficiency (\>60% abnormal rate at 1.6 ng) than the splicing-MO (around 35% abnormal rate at 6 ng) to induce curved notochord phenotypes under our experimental conditions, we thus adopted the ATG-MO throughout our study.

Zebrafish *col2a1a* is down-regulated in the notochord of*znf219L* morphants
----------------------------------------------------------------------------

Up to date, it has been reported that at least five collagen genes; collagen type II alpha-1a (col2a1a), collagen type II alpha-1b (col2a1b), collagen type VIII alpha-1a (col8a1a), collagen type XI alpha-1a (col11a1a), and collagen type XXVII alpha-1a (col27a1a) are expressed in notochord and involved in its formation [@B27], [@B44]-[@B46], [@B54]. Because znf219L transcripts were first detected at 22 hpf in notochord only as shown in Fig. [2](#F2){ref-type="fig"}D, panels a and a\', we thus wonder whether ZNF219L may regulate the expression of those five genes in notochord. Therefore, the znf219L morphants at 24 hpf were analyzed by whole-mount in situ hybridization using probes for different collagen genes. Interestingly, knockdown of znf219L by morpholino only led to the reduced expression of col2a1a specifically in zebrafish notochord (Fig. [4](#F4){ref-type="fig"}A, panels a and a\'), while the expression of other collagen genes was not affected in notochord (Figs. [4](#F4){ref-type="fig"}B to 4E, panels a and a\'). These data suggest that znf219L functions as a specific regulator that targets the col2a1a gene and lacking of it does not have significant effect on the formation of notochord. And, it is possible that other factors involved in regulation of these collagen genes expression in notochord other than ZNF219L.

According to the previous report [@B27], we similarly established a transgenic *Tg(col2a1a*: GFP) zebrafish with GFP expression in the craniofacial cartilage, ear, notochord, floor plate, hypochord and pectoral fins (Fig. [5](#F5){ref-type="fig"}A, B, panels a and a\'). The expression pattern was similar to that of endogenous *col2a1a*[@B27]. We then injected ATG-MO into embryos of this transgenic line at 2-4 cells stage and observed that knockdown of *znf219L* only decreased the GFP signal in the notochord, not in other tissues, of *Tg*(*col2a1a*: GFP) fish at 24 hpf (Fig. [5](#F5){ref-type="fig"}C, panels a, a\' b, b\' c, and c\'). These data are consistent with the result mentioned above that knockdown of znf219L by morpholino led to the reduced expression of *col2a1a* specifically in notochord of wild-type zebrafish (Fig. [4](#F4){ref-type="fig"}A, panels a and a\').

ZNF219L regulates *col2a1a*promoter activity via binding to GGGGG motifs
------------------------------------------------------------------------

It has been previously reported that mammalian ZNF219 can localize to the nucleus, where it functions as a transcriptional regulator. In addition, ZNF219 has been reported to bind the GGGGG motif in the *col2a1*promoter region [@B37]. According to those results mentioned above, we further examined whether ZNF219L activates the zebrafish *col2a1a* promoter in cultured cells. Initially, we had performed serial deletions ranged from 2.0-kb to -386 bp region of col2a1a promoter in luciferase assay. It showed no obvious difference in the activity between 2.0-kb and -386 bp region of col2a1a gene promoter. Therefore, we believe that -386 region alone could be responsible for col2a1a expression. We constructed an expression vector containing a *col2a1a* promoter proximal region, 386 base pairs upstream of the ATG codon (designated as the -386 region), which contains all three ZNF219L binding sites. A luciferase assay construct containing the -386 proximal region of the *col2a1a*promoter (henceforth referred to as the *col2a1a*proximal promoter luciferase construct) was used to drive luciferase expression (Fig. [6](#F6){ref-type="fig"}A). The *col2a1a*proximal promoter luciferase construct was co-transfected with a ZNF219L overexpression construct into grass carp CF cells, and luciferase activity was measured to compare promoter activity in cells with or without ZNF219L overexpression. Luciferase activity of the *col2a1a*proximal promoter was elevated by overexpression of ZNF219L (Fig. [6](#F6){ref-type="fig"}A). However, in order to confirm that binding of ZNF219L to the *col2a1a*proximal promoter was required for the observed increase in luciferase activity, we mutated the three ZNF219L binding sites. It was previously reported that mutation of the ZNF219 recognition sequence GGGGG to GGCGG reduced its binding affinity in mammals [@B37]. Therefore, we mutated all three ZNF219L binding sites from GGGGG to GAAAG (thereby mutating two extra base pairs as compared to the earlier study) in the *col2a1a*proximal promoter. As shown in panel b, mutation of these motifs reduced promoter activity in cells with and without ZNF219L overexpression. These results suggest that zebrafish ZNF219L can specifically up-regulate the transcriptional activity of the c*ol2a1a* promoter via binding to the GGGGG motifs. To confirm this hypothesis, we performed a pull-down assay with biotin-labeled oligonucleotide probes, each containing one of the three GGGGG motifs. We found that ZNF219L could directly bind to all three GGGGG motifs in an independent manner. The association between ZNF219L and each motif was specific, because the addition of a competitive non-biotin-labeled probe effectively inhibited binding (Fig. [6](#F6){ref-type="fig"}B).

We next used an *in vitro*binding assay to identify which zinc finger domain is required for association of ZNF219L with the *col2a1a* gene promoter. A series of deletion mutants of ZNF219L were generated for use in the assay, as shown in Fig. [6](#F6){ref-type="fig"}C. A deletion mutant without the sixth, seventh, eighth, and ninth zinc finger domains (upper panel) was not pulled down by biotin-labeled oligonucleotides containing the three GGGGG motifs, indicating that it could not bind to the *col2a1a* gene promoter (△6, Fig. [6](#F6){ref-type="fig"}D). However, the deletion mutant without the seventh, eighth, and ninth zinc finger domains (△3) and another deletion mutant with only the ninth zinc finger domain (△4) interacted with biotin-labeled oligonucleotides. Thus, both sixth and ninth zinc finger domains are involved in binding to the GGGGG motifs Lysates of cells expressing different ZNF219L mutants were analyzed by immunoblotting with anti-HA antibody as control in the lower panel.

Altogether, our data indicate that ZNF219L is required for the regulation of *col2a1a*promoter activity via binding to GGGGG motifs in cultured cells.

Discussion
==========

In this study, we described the cloning of zebrafish ZNF219-related protein based on mammalian ZNF219; this protein consists of 1095 amino acids and 9 classical C2H2 zinc finger domains. The overall amino acid sequence of this protein has low identity (20%) with that of human ZNF219, but higher identity was observed in each C2H2 zinc finger domain (Fig. [1](#F1){ref-type="fig"}). We further demonstrated that (1) its expression in the midbrain hindbrain boundary, hindbrain and notochord (Fig. [2](#F2){ref-type="fig"}); (2) its morpholino knockdown caused partial notochord phenotype and led to down-regulation of *col2a1a* mRNA expression in notochord (Figs. [3](#F3){ref-type="fig"}-[5](#F5){ref-type="fig"}); (3) its ability to bind to the GGGGG motifs in the *col2a1a* gene promoter (Fig. [6](#F6){ref-type="fig"}) and (4) the sixth and/or ninth zinc finger domains of ZNF219L are required for binding to the *col2a1a* gene promoter (Fig. [6](#F6){ref-type="fig"}D). Taken together, these data indicate that zebrafish ZNF219L functions in regulating *col2a1a* expression in the notochord.

Zinc finger proteins contain one to forty zinc finger domains [@B38]. Most of these proteins can be classified into three groups, based on the number and pattern of the zinc fingers: triple-C2H2, multiple-adjacent-C2H2, and separated-paired-C2H2 finger proteins [@B55]. Human ZNF219 is a separated-paired-C2H2 finger protein, which contains nine zinc finger domains. Proteins with nine zinc finger domains may require two to four of these domains for DNA binding, while the others act as protein-protein interaction domains. For example, the friend of GATA (FOG) family-FOG-1 protein uses the first, fifth, sixth, and ninth zinc finger domains for protein-protein interaction, while the FOG-2 protein uses the first, fifth, sixth, and eighth zinc finger domains to interact with GATA-1 [@B56]. The first three zinc finger domains of TFIIIA (also a nine zinc finger domain protein) are used for DNA binding, and the fourth to seventh zinc finger domains are used for RNA binding [@B57], [@B58]. Human ZNF219 was reported to recognize and bind to specific DNA sequences through two regions: the first three zinc finger domains, and a paired zinc finger domain (fifth and sixth fingers) [@B35]. The latter was also demonstrated to interact with Sox9 [@B37]. Thus, the fifth and sixth zinc finger domains of human ZNF219 are required for DNA binding. In this study, we demonstrated that zebrafish ZNF219L is a protein with nine zinc finger domains, and its sixth and ninth zinc finger domains are required for binding to the promoter of *col2a1a* (Fig. [6](#F6){ref-type="fig"}D). However, the sixth zinc finger domain of zebrafish ZNF219L is not present in mammalian ZNF219 (Fig. [1](#F1){ref-type="fig"}), and the ninth zinc finger domain of mammalian ZNF219 is not involved in DNA binding [@B35], [@B37]. Therefore, zebrafish ZNF219L may bind DNA through specific and unique zinc finger domains.

Human ZNF219 was determined to be either a transcriptional repressor or enhancer, depending on the target gene and the cell type. Human ZNF219 represses expression of high mobility group nucleosomal binding protein 1 (HMGN1) in 293 cells (a human embryonic kidney cell line) [@B35], but enhances expression of aggrecan, *Col2a1*, and *Col11a2* in C3H10T1/2 mesenchymal cells through associating with Sox9 [@B37]. In this study, we demonstrated that knockdown of zebrafish*znf219L* resulted in curved notochord phenotype with only down-regulation of *col2a1a* without affecting other four collagen genes-*col2a1b, col8a1a, col11a1a, and col27a1a*expression the notochord (Figs. [3](#F3){ref-type="fig"}-[5](#F5){ref-type="fig"}). Also, zebrafish ZNF219L enhances transcription of *col2a1a* in carp CF-cells through recognized the same GGGGG motifs as in mammals (Fig. [6](#F6){ref-type="fig"}). However, zebrafish *sox9a* regulates expression of *col2a1a* in craniofacial cartilage, but *sox9a* knockdown did not affect *col2a1a* expression in the notochord [@B27]. Interestingly, the GFP signal in the Tg(*col2a1a*:GFP) transgenic zebrafish line was detected in many tissues, including craniofacial cartilage, ear, notochord, floor plate, hypochord and pectoral fins, in a pattern similar to that of endogenous *col2a1a*[@B27]. Knockdown of *znf219L*and *sox9a* only affected the GFP signal in the notochord and craniofacial cartilage, respectively. This suggests that other factors may be required for *col2a1a* expression in other tissues.

Recent studies have indicated that other zinc finger proteins are also involved in chondrogenesis. For example, zinc finger protein 521 (ZNF521) acts as a transcriptional regulator during bone formation, and is also a target gene of parathyroid hormone-related peptide, which regulates growth plate chondrocyte proliferation and differentiation [@B59]-[@B61]. Zinc finger protein 145 (ZNF145) functions in chondrogenesis by enhancing the expression of *sox9* in human mesenchymal stem cells (MSCs) [@B62]. This suggests that zebrafish ZNF219L may regulate *col2a1a* expression in the notochord directly, as a single factor. It is likely that ZNF219L and Sox9a act separately, to regulate *col2a1a* expression in the notochord and craniofacial cartilage, respectively.

In summary, our results demonstrate that the reduction of zebrafish ZNF219L causes down-regulation of *col2a1a* gene expression in notochord and partial notochord abnormalities. Our data indicates that zebrafish ZNF219L acts as an important transcriptional factor in regulating the *col2a1a*gene expression in notochord.
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======================
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![**Alignment of amino acid sequences of zebrafish ZNF219L and mouse and human ZNF219 proteins.** (A) Zebrafish ZNF219L protein contains three paired zinc finger domains (aa 278-325, 358-408, and 701-749) and three single zinc finger domains. (B) The deduced amino acid sequence of zebrafish ZNF219L was aligned with those of mouse and human ZNF219 proteins. All three proteins contain eight highly-conserved C2H2-type zinc finger domains (indicated by bars labeled with C and H). Both mammalian ZNF219 and zebrafish ZNF219 possess a non-homologous single zinc finger domain (the second and sixth domain, respectively). The accession numbers for mouse and human *znf219*are NM_027248.2 and NM_001102454, respectively.](ijbsv09p0872g001){#F1}

![**Genomic organization and expression profiles of zebrafish *znf219L*.** Genomic organization of zebrafish *znf219L*, and the mouse and human *znf219* genes were shown in panel (A). Coding regions are shown as filled boxes numbered from 3 to 5. The 5\'- and 3\'-untranslated regions are shown as open boxes, while solid lines indicate introns. RT-PCR was performed with gene-specific primers. β*-actin*was used as an internal control to normalize the amount of cDNA prepared from different adult zebrafish tissues (B) and from zebrafish embryos at different developmental stages (C). The developmental expression profile of zebrafish *znf219L*mRNA was examined in embryos from 12 hpf to 144 hpf. Blank PCR was performed using gene-specific primers and β*-actin*primers without the addition of cDNA template. Whole-mount *in situ* hybridization with antisense *znf219L* was performed at the indicated times post-fertilization (D). The images were taken from 22 to 48 hpf in the lateral view (panels a, b) and 48 hpf in dorsal view in panel c. The boxed region is enlarged to show the signal in the notochord (nc) from 22 to 48 hpf of both lateral and dorsal view (panels a\', b\', and c\'). Dorsal view of*znf219L* mRNA signals in midbrain hinfbrain boundry (mhb), and hindbrain (hb) were detected from 48 to 96 hpf (panel d, e, and f). mhb, midbrain hindbrain boundry; hb, hindbrain; ov, otic vesicle; pf, pectoral fin, nc, notochord. Scale bars=100 μm.](ijbsv09p0872g002){#F2}

![**Knockdown of *znf219L* caused notochord abnormalities.**Knockdown of *znf219L* in wild-type zebrafish embryos using an ATG-MO (A) or a splicing-MO (B) resulted in abnormal notochord phenotype with partial curving of notochord (panels b, and b\'). Black arrowheads in panel b\' indicate partial curved notochord abnormalities. Scale bars=100 μm. (C) The percentage of abnormal notochord phenotypes in zebrafish embryos was correlated with MO dose, for both types of *znf219L* MO tested. Co-injection of ATG-MO with *p53*-MO did not decrease the ratio of abnormal notochord phenotypes. (D) Schematic depicting the binding positions of the splicing-MO and primers used for detecting *znf219L*-derived RNA species by RT-PCR (panel a). Representative images from RT-PCR analyses of control (C) and splicing MO (MOs)-injected embryos (panel b). RT-PCR was performed with splicing-MO F1-R1 and F2-R1 primers. β*-actin*was used as an internal control.](ijbsv09p0872g003){#F3}

![**Knockdown of *znf219L*only caused decreased expression of *col2a1a* in the notochord.**Expression of *col2a1a* (A), *col2a1b*(B)*, col8a1a*(C)*, col11a1a*(D)*,*and*col27a1a* (E) was examined in *znf219L* ATG-MO by *in situ* hybridization using probes for each collagen gene. Only *col2a1a* expression in notochord was observed to decrease significantly, other four genes were not. White arrows indicate decreases in the expression of endogenous *col2a1a*in notochord. (Fig. [4](#F4){ref-type="fig"}A, panel a\'). Scale bars=100 μm.](ijbsv09p0872g004){#F4}

![**Knockdown of *znf219L*resulted in decreasing GFP expression in notochord of a transgenic zebrafish line, Tg(*col2a1a*:GFP).** According to the previous report [@B27], we similarly established a transgenic Tg(*col2a1a*: GFP) zebrafish using the upstream 2.1-kb promoter region. The GFP signals in this zebrafish line were observed in ear, notochord, floor plate, and hypochord at 24 hpf (A), while GFP signals in other regions, such as craniofacial cartilage, and pectoral fins were observed at 72 hpf (B). Merged bright-field and fluorescence images are shown in panel a\', while fluorescence images are shown in panel a. Injection of this transgenic zebrafish line with *znf219L* ATG-MO at 2-4 cells stage (C) resulted in a decrease in GFP expression specifically in the notochord (panels a, and a\', lateral view), but not in craniofacial cartilage (panels b and b\', ventral view) and ear (panels c, and c\', lateral view). White arrows indicate the decrease in GFP expression in notochord. m, Meckel\'s cartilage; cc, craniofacial cartilage; ov, optic vesicle; nc, notochord; fp, floor plate; hc, hypochord. Scale bars=100 μm.](ijbsv09p0872g005){#F5}

![**ZNF219L regulates the *col2a1a* proximal promoter in cultured cells.**(A) The effect of ZNF219L on *col2a1a*promoter activity was studied in grass carp CF cells. The *col2a1*gene -386 proximal promoter luciferase constructs, containing either wild-type (GGGGG) or mutant (GAAAG) potential ZNF219L binding sites, were co-transfected with a ZNF219L expression vector into grass carp CF cells. The luciferase activity of co-transfected cell lysates was measured at 48 hours after transfection. Data represent mean ± s.d. (*n*=3) (panel b). (B) ZNF219L binds to the three GGGGG motifs in the *col2a1*proximal promoter. NIH3T3 cell lysates were transfected with empty or HA-ZNF219L vector, and then incubated with biotinylated oligonucleotide containing one of the three GGGGG motifs of the *col2a1*gene promoter. Association of the ZNF219L protein with each oligonucleotide was determined by immunoblotting with anti-HA antibody after precipitation with streptavidin agarose beads. (C) Schematic diagram of HA-tagged deletion mutants of ZNF219L. The black bars represent zinc finger domains. (D) Binding of ZNF219L deletion mutants to the zebrafish *col2a1a* gene promoter *in vitro* (upper panel). Lysates of cells expressing each ZNF219L mutant were precipitated with biotinylated oligonucleotide containing the *col2a1a*gene promoter GGGGG motif. Bound protein was subsequently detected by immunoblotting with anti-HA antibody. The star (\*) indicates the failure of the ZNF219L Δ6 mutant to interact with the probe. Lysates of cells expressing each ZNF219L mutant were detected by immunoblotting with anti-HA antibody as control in lower panel.](ijbsv09p0872g006){#F6}

###### 

Primers used for PCR amplification of cDNA encoding full-length and deletion mutations of zebrafish z*nf219L*.

  -------------------------------------------------------------------------------------------
  Gene           Sequences of forward (F) and reverse (R) primers
  -------------- ----------------------------------------------------------------------------
  *znf219L*      HindIII-F, 5\'- [AAA AGC TT]{.ul}A TGG ATT CCC CAC CAG AAT GTA TGC TG-3\'\
                 KpnI-R, 5\'- [GGG GTA CC]{.ul}C TAT TCC CCC AAG ACA CCT TCC TCC TC-3\'

  *znf219L*-△1   HindIII-F, 5\'- [AAA AGC TT]{.ul}CCA GAA ACT CCC GTC CCA CAA ATG TCT-3\'\
                 KpnI-R, 5\'- [GGG GTA CC]{.ul}C TAT TCC CCC AAG ACA CCT TCC TCC TC-3\'

  *znf219L*-△2   HindIII-F, 5\'- [AAA AGC TT]{.ul}CAT CAG CAT CCT TCA TCA C-3\'\
                 KpnI-R, 5\'- [GGG GTA CC]{.ul}C TAT TCC CCC AAG ACA CCT TCC TCC TC-3\'

  *znf219L*-△3   HindIII-F, 5\'- [AAA AGC TT]{.ul}A TGG ATT CCC CAC CAG AAT GTA TGC TG-3\'\
                 KpnI-R, 5\'- [GGG GTA CC]{.ul}T GGA CAT GCC CAC TCT GGC AC -3\'

  *znf219L*-△4   HindIII-F, 5\'- [AAA AGC TT]{.ul}C GTG AGC AAA GGA ATG CTA TGG CA-3\'\
                 KpnI-R, 5\'- [GGG GTA CC]{.ul}C TAT TCC CCC AAG ACA CCT TCC TCC TC-3\'

  *znf219L*-△5   HindIII-F, 5\'- [AAA AGC TT]{.ul}A TGG ATT CCC CAC CAG AAT GTA TGC TG-3\'\
                 KpnI-R, 5\'- [GGG GTA CC]{.ul}T GCC ATA GCA TTC CTT TGC TCA CG-3\'

  *znf219L*-△6   HindIII-F, 5\'- [AAA AGC TT]{.ul}A TGG ATT CCC CAC CAG AAT GTA TGC TG-3\'\
                 KpnI-R, 5\'- [GGG GTA CC]{.ul}G TTA CCC ATT TCT GCA ACC TG-3\'
  -------------------------------------------------------------------------------------------
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